We Accelerate Discovery

Reporter - Search Portfolios of Funded Research

Subscribe to the NIH Roadmap E-mail List

  • Highlights

    NIH-funded KOMP2 program leads
    the way in efforts to ensure
    reproducibility and enhance transparency in research

    Click for More >>

    Study Finds Potential New Drug Target for Lung Cancer

  • Highlights

    FINANCIAL INCENTIVES
    CAN INCREASE THE
    EFFECTIVENESS OF
    SMOKING CESSATION PROGRAMS

    Click for More >>

    Financial Incentives can Increase the Effectiveness of Smoking Cessation Programs

  • Highlights

    New resource shows how differences in DNA affect
    gene activity and
    disease susceptibility

    Click for More >>

    New resource shows how differences in DNA affect gene activity and disease susceptibility

  • Highlights

    New Method Using
    Llamas Is Set
    To Transform
    Biomedical Research

    Click for More >>

    New Method Using Llamas Is Set To Transform Biomedical Research

  • Highlights

    Common Fund-supported
    researchers map epigenome
    of more than 100
    tissue and cell types

    Click for More >>

    Common Fund-supported researchers map epigenome of more than 100 tissue and cell types

    New! Stimulating Peripheral Activity to Relieve Conditions (SPARC) Program Manager position
    Details available by clicking the image below.

                       

    Applications will be reviewed starting July 1, 2015.

    New! Gabriella Miller Kids First Research Program Funding Opportunity!

    The NIH is soliciting applications from researchers to use whole genome sequencing at a National Human Genome Research Institute (NHGRI)-supported sequencing center to investigate the genetics of structural birth defects, and the genetic contributions to childhood cancers, and the genomic contributions to treatment failure for childhood sarcomas. Applications are due July 27, 2015. Read the Funding Opportunity Announcement.

    Undiagnosed Diseases Network Gene Function Research (R21) Funding Opportunity!

    This Funding Opportunity Announcement (FOA) (RFA-RM-15-004) is to support gene function studies in collaboration with the NIH Intramural Undiagnosed Diseases Program (NIH-UDP) to investigate the underlying genetics, biochemistry and pathophysiology of newly diagnosed diseases (Diseases of Interest) in association with the respective gene variant(s) identified through the NIH-UDP. More information can be found on the Common Fund UDN homepage

    • Letter of Intent Due Date: May 24, 2015
    • Application Due Date: June 24, 2015
     

    The NIH Common Fund is managed by the Office of Strategic Coordination, part of the Division of Program Coordination, Planning and Strategic Initiatives (DPCPSI).

    Read more >